Pfizer Inc. Stock Hits Day Low Amid Price Pressure, Reaches $26.39

Pfizer Inc. experienced a notable decline today, with the stock dropping by 3.43% to touch an intraday low of USD 26.39. This performance contrasts sharply with the S&P 500, which saw a slight increase of 0.01% during the same period. Over the past week, Pfizer has shown a positive trend, gaining 10.82%, and it has also performed well over the last month with a 6.23% increase. However, the stock's year-to-date performance remains negative at -0.38%, and it has underperformed the S&P 500 over the past three years, with a significant decline of 38.66%.
Despite the recent downturn, Pfizer maintains a strong financial position, highlighted by a high return on capital employed (ROCE) of 16.86% and a low debt-to-EBITDA ratio of 2.16 times. The company has reported positive net profit growth of 53.8% over the last nine months and offers a high dividend yield of 409.58%. With institutional holdings at 68.68%, Pfizer's fundamentals continue to attract attention, even amid its current stock performance challenges.